Suppr超能文献

程序性细胞死亡配体 1 表达在听神经鞘瘤中的意义。

The significance of programed cell death-ligand 1 expression in vestibular schwannoma.

机构信息

Department of Otorhinolaryngology-Head and Neck Surgery, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Republic of Korea.

Department of Pathology, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Republic of Korea.

出版信息

Brain Behav. 2023 Sep;13(9):e3137. doi: 10.1002/brb3.3137. Epub 2023 Jun 27.

Abstract

BACKGROUND

The association between programed cell death-ligand 1 (PD-L1) and tumor-infiltrating lymphocytes (TILs) in vestibular schwannoma (VS) has been investigated in a few studies. These published studies report a difference in the PD-L1 positivity rate in malignant peripheral nerve sheath tumors. We examined PD-L1 expression and lymphocyte infiltration in patients with VS who had undergone surgical resection and investigated the association between PD-L1 expression and clinicopathological features.

METHODS

The expression of PD-L1, CD8, and Ki-67 in 40 VS tissue specimens was investigated using immunohistochemistry, and a clinical review of the patients was performed.

RESULTS

Of the 40 VS samples, 23 (57.5%) were positive for PD-L1 and 22 (55%) were positive for CD8. No significant differences in age, tumor size, pure-tone audiometry, speech discrimination, or Ki-67 expression were observed between patients in the PD-L1-positive and PD-L1-negative groups. A higher level of CD8-positive cell infiltration was observed in PD-L1-positive tumors than in PD-L1-negative tumors.

CONCLUSION

We demonstrated that PD-L1 was expressed in VS tissues. Although no correlation was identified between clinical characteristics and PD-L1 expression, the association between PD-L1 and CD8 was confirmed. Thus, additional research on targeting PD-L1 is necessary to improve immunotherapy for VS in the future.

摘要

背景

程序性死亡配体 1(PD-L1)与肿瘤浸润淋巴细胞(TILs)在听神经鞘瘤(VS)中的关联已在少数研究中进行了研究。这些已发表的研究报告称,恶性外周神经鞘瘤的 PD-L1 阳性率存在差异。我们检查了接受手术切除的 VS 患者的 PD-L1 表达和淋巴细胞浸润,并研究了 PD-L1 表达与临床病理特征之间的关联。

方法

使用免疫组织化学法检测 40 例 VS 组织标本中 PD-L1、CD8 和 Ki-67 的表达,并对患者进行临床回顾。

结果

在 40 例 VS 样本中,23 例(57.5%)PD-L1 阳性,22 例(55%)CD8 阳性。PD-L1 阳性组和 PD-L1 阴性组患者的年龄、肿瘤大小、纯音听阈、言语辨别率或 Ki-67 表达无显著差异。PD-L1 阳性肿瘤中 CD8 阳性细胞浸润水平高于 PD-L1 阴性肿瘤。

结论

我们证明了 PD-L1 在 VS 组织中表达。尽管未发现临床特征与 PD-L1 表达之间存在相关性,但证实了 PD-L1 与 CD8 之间的关联。因此,未来有必要针对 PD-L1 进行更多的研究,以改善 VS 的免疫治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c53/10498056/d845245a6382/BRB3-13-e3137-g002.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验